Drugs / CJ-40002
last change Sep 2015 re-read 3 minutes ago

CJ-40002

Investigated by
HK inno.N Corporation

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02146625 Nov 2014 → Mar 2015 — HK inno.N Corporation Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CJ-40002 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02146625 ↗
Route Subcutaneous “single SC injection” NCT02146625 ↗